The CPA’s Panel for physicians and medical professionals addressed “New Psychedelic Substances”
January 13, 2022 — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announces that its newly appointed VP Business Development, psychedelic medicine expert Mr. Mark Haden, presented at the Canadian Psychedelics Association (“CPA“) event, that was held earlier this week.
The event included a panel, for physicians and medical professionals only, in the topic of “New Psychedelic Substances”.
Mr. Mark Haden presented new psychedelic substances. Among other novel psychedelics, he discussed Clearmind’s innovative psychedelic candidate- MEAI, intended for alcohol-use-disorder.
Receiving an invitation from the CPA is a testimony to Mr. Haden’s expertise and knowledge of the psychedelic field. Participating in exclusive events and panels is part of the Company’s efforts to raise awareness to its innovative psychedelic treatments amongst medical professionals, industry and potential partners in North America.
About Clearmind Medicine Inc.
Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.
The Company’s intellectual portfolio currently consists of four patent families. The Company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Shares of Clearmind are listed for trading on the Canadian Securities Exchange under the symbol “CMND“, the Frankfurt Stock Exchange under the symbol “CWYO” and on the OTC pink under the symbol “CMNDF“.